FDA Expands Approval Of Eli Lilly's Olumiant For Adolescents with Autoimmune Hair Loss

기사 요약

FDA approves Eli Lilly's once-daily pill Olumiant for adolescents aged 12 and older with severe alopecia areata following Phase 3 trials.